Evaluation of the Feasibility and Safety of Laryngoscopic Microsurgery Under Non-intubation Anesthesia

Sponsor
Kaohsiung Veterans General Hospital. (Other)
Overall Status
Completed
CT.gov ID
NCT05420649
Collaborator
(none)
49
1
3
17.1
2.9

Study Details

Study Description

Brief Summary

Nonintubated anesthesia applied in combination with high-flow nasal oxygen (HFNO) is an alternative strategy for laryngeal microsurgery (LMS). LMS is a common procedure in otolaryngology that typically requires endotracheal tube intubation under general anesthesia. Endotracheal tube intubation causes complications; a nonintubated strategy can avoid these complications and provide a clearer surgical field of vision, enabling vocal cord inspection and disposal. Administering a muscle relaxant can also help prevent bucking during surgery but can engender apnea and hypercapnia, which may have negative effects on hemodynamics. Therefore, the investigators assessed the effectiveness of a superior laryngeal nerve block (SLNB) with intravenous general anesthesia in maintaining spontaneous breathing and improving safety during LMS with nonintubated anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-intubated Laryngomicrosurgery
N/A

Detailed Description

Laryngeal microsurgery (LMS) is among the most common operations in otolaryngology and typically requires general anesthesia administered through endotracheal tube intubation. Endotracheal tube intubation provides stable gas exchange, protects the airways by preventing secretions from falling into the lower respiratory tract, and enables the monitoring of parameters such as tidal volume and end-tidal CO2.

Nonintubated anesthesia applied in combination with transnasal humidified rapid-insufflation ventilatory exchange or high-flow nasal oxygen (HFNO) is another option for LMS. LMS with nonintubated anesthesia can avoid the complications caused by endotracheal tube intubation such as oral tissue trauma, tracheal trauma, and dental injury. Furthermore, LMS with nonintubated anesthesia can provide a clearer surgical field of vision that allows the vocal cords to be inspected and disposed of completely. Current practice in LMS with nonintubated anesthesia is to administer a muscle relaxant to help avoid bucking during the procedure. However, the administration of a muscle relaxant can lead to apnea and hypercapnia, which may negatively affect hemodynamics. Therefore, the investigators investigated the use of a superior laryngeal nerve block (SLNB) with intravenous general anesthesia to help the patient maintain spontaneous breathing and provide higher surgical safety during LMS with nonintubated anesthesia.

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Feasibility and Safety of Laryngoscopic Microsurgery Under Non-intubation Anesthesia With Combination of Superior Laryngeal Nerve Block
Actual Study Start Date :
Oct 20, 2020
Actual Primary Completion Date :
Mar 22, 2022
Actual Study Completion Date :
Mar 23, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Intubated general anesthesia LMS

Patients received LMS with intubated general anesthesia

Experimental: Non-intubated LMS with apnea

Patients received non-intubated LMS with administration of muscle relaxant and optiflow(HFNO) device.

Procedure: Non-intubated Laryngomicrosurgery
Non-intubated LMS was performed with assistance of Optiflow (HFNO).

Experimental: Non-intubated LMS with spontaneous breathing

Patients received non-intubated LMS optiflow(HFNO) device and maintained spontaneous breathing.

Procedure: Non-intubated Laryngomicrosurgery
Non-intubated LMS was performed with assistance of Optiflow (HFNO).

Outcome Measures

Primary Outcome Measures

  1. PaCO2 after Laryngomicrosurgery [ABG was measured immediately after the end of LMS]

    ABG was measured immediately after the end of LMS

Secondary Outcome Measures

  1. pH after Laryngomicrosurgery [ABG was measured immediately after the end of LMS]

    ABG was measured immediately after the end of LMS

  2. Heart rate (HR) [during the LMS procedure]

    Hemodynamic data were measured every 5 minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient who needed to undergo LMS.
Exclusion Criteria:
  • Severe airway obstruction.

  • Severe airway disease.

  • American Society of anesthesiologists (ASA) physical state > III.

  • Pregnancy or body mass index (BMI) ≥ 40 kg/m2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaohsiung Veterans General Hospital Kaohsiung Taiwan 81362

Sponsors and Collaborators

  • Kaohsiung Veterans General Hospital.

Investigators

  • Principal Investigator: Yuan Yi Chia, Director, Kaohsiung Veterans General Hospital.
  • Study Director: Yu Ting Kuo, physician, Kaohsiung Veterans General Hospital.
  • Study Director: Ting Shou Chang, physician, Kaohsiung Veterans General Hospital.
  • Study Chair: Chih Chi Tsai, RA, Kaohsiung Veterans General Hospital.
  • Study Director: Li-Ya Tseng, physician, Kaohsiung Veterans General Hospital.
  • Study Director: Pei-Wen Shen, physician, Kaohsiung Veterans General Hospital.

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.
ClinicalTrials.gov Identifier:
NCT05420649
Other Study ID Numbers:
  • KSVGH20-CT9-09
First Posted:
Jun 15, 2022
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022